Literature DB >> 24674709

Comparison of two approaches of intestinal absorption by puerarin.

Hewei Li1, Ling Dong1, Yang Liu2, Gang Wang3, Lei Zhang1, Yanjiang Qiao4.   

Abstract

INTRODUCTION: Everted gut sac (EGS) and in situ single-pass intestinal perfusion (SPIP) have been widely used in the study of drug absorption and biopharmaceutical classification systems (BCS). Furthermore, they could also be applied in the research of drug intestinal first-pass metabolism. Since most of Chinese herbal medicines (CHMs) are orally administrated, it is necessary to study the permeability of active ingredients of CHMs. Thus, we attempted to apply the EGS and SPIP models to study the permeability of puerarin, one of the active marker compounds (AMCs) of Puerariae Radix.
METHODS: In the present study, three rat models of ex vivo and in situ, EGS, SPIP, and in situ intestinal perfusion with venous sampling (IPVS), were established to determine the permeability coefficient of puerarin. The apparent permeability coefficient (Papp) was obtained by EGS. The SPIP model was used to determine the effective permeability coefficient (Peff) in different intestinal segments. The blood permeability coefficient (Pblood) was determined by IPVS. Puerarin concentration of perfusion and blood samples were measured by HPLC.
RESULTS: Puerarin could filter into EGS incubated in aqueous extract of Puerariae Radix or puerarin solution. In the SPIP experiment, the concentration effect on Peff was observed in the ileum, but not in the other three intestinal segments. The Pblood was 0.068±0.002×10(-5)cm/s and was 16-fold lower than the Peff (1.114±0.153×10(-5)cm/s) in the IPVS experiment at 80μg/mL puerarin. As expected, the Peff (1.24±0.11×10(-5)cm/s) in SPIP did not differ from the Peff in IPVS. The Papp was 0.199×10(-5)cm/s at 1200μg/mL puerarin, 10-fold lower than Peff (2.047±0.116×10(-5)cm/s) in SPIP. DISCUSSION: Three models for permeability were successfully practiced in the study of puerarin absorption and our research strategy will be useful for herbal constituent absorption in the future.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Everted gut sac; In situ intestinal perfusion with venous sampling; In situ single-pass intestinal perfusion; Methods; Puerarin

Mesh:

Substances:

Year:  2014        PMID: 24674709     DOI: 10.1016/j.vascn.2014.03.170

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  5 in total

1.  Antioxidative Activity Evaluation of High Purity and Micronized Tartary Buckwheat Flavonoids Prepared by Antisolvent Recrystallization.

Authors:  Yanjie Liu; Xiaoyu Sui; Xiuhua Zhao; Siying Wang; Qilei Yang
Journal:  Foods       Date:  2022-05-05

2.  Establishment of a Novel In Situ Rat Model for Direct Measuring of Intestinal Drug Absorption: Confirmation of Inhibitory Effects of Daijokito on the Absorption of Ranitidine.

Authors:  Weibin Qian; Junichi Hasegawa; Jie Yang; Yusuke Endo; Junichiro Miake
Journal:  Yonago Acta Med       Date:  2018-12-27       Impact factor: 1.641

3.  Effect of puerarin on human choriocarcinoma cells.

Authors:  Bao Lidao; Wang Yi; Ma Ruilian; Ren Xianhua; Lv Haijun; B Agula
Journal:  Open Med (Wars)       Date:  2015-04-28

4.  Integrated Strategy From In Vitro, In Situ, In Vivo to In Silico for Predicting Active Constituents and Exploring Molecular Mechanisms of Tongfengding Capsule for Treating Gout by Inhibiting Inflammatory Responses.

Authors:  Wenning Yang; Xiaoquan Jiang; Jingtong Liu; Dongying Qi; Zhiqiang Luo; Guohua Yu; Xueyan Li; Muli Sen; Hongjiao Chen; Wei Liu; Yang Liu; Guopeng Wang
Journal:  Front Pharmacol       Date:  2021-11-29       Impact factor: 5.810

Review 5.  Developments in Methods for Measuring the Intestinal Absorption of Nanoparticle-Bound Drugs.

Authors:  Wei Liu; Hao Pan; Caiyun Zhang; Liling Zhao; Ruixia Zhao; Yongtao Zhu; Weisan Pan
Journal:  Int J Mol Sci       Date:  2016-07-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.